BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8940083)

  • 1. Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor.
    Kamalati T; Jolin HE; Mitchell PJ; Barker KT; Jackson LE; Dean CJ; Page MJ; Gusterson BA; Crompton MR
    J Biol Chem; 1996 Nov; 271(48):30956-63. PubMed ID: 8940083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intracellular tyrosine kinase Brk sensitizes non-transformed cells to inducers of apoptosis.
    Haegebarth A; Nunez R; Tyner AL
    Cell Cycle; 2005 Sep; 4(9):1239-46. PubMed ID: 16082217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.
    Weaver AM; Silva CM
    Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.
    Ai M; Liang K; Lu Y; Qiu S; Fan Z
    Cancer Biol Ther; 2013 Mar; 14(3):237-45. PubMed ID: 23291984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation.
    Kamalati T; Jolin HE; Fry MJ; Crompton MR
    Oncogene; 2000 Nov; 19(48):5471-6. PubMed ID: 11114724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
    Lukong KE; Larocque D; Tyner AL; Richard S
    J Biol Chem; 2005 Nov; 280(46):38639-47. PubMed ID: 16179349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRK tyrosine kinase expression in a high proportion of human breast carcinomas.
    Barker KT; Jackson LE; Crompton MR
    Oncogene; 1997 Aug; 15(7):799-805. PubMed ID: 9266966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated association of protein kinase B/Akt with breast tumor kinase.
    Zhang P; Ostrander JH; Faivre EJ; Olsen A; Fitzsimmons D; Lange CA
    J Biol Chem; 2005 Jan; 280(3):1982-91. PubMed ID: 15539407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
    Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
    Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.
    Fan G; Aleem S; Yang M; Miller WT; Tonks NK
    J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion.
    Shen CH; Chen HY; Lin MS; Li FY; Chang CC; Kuo ML; Settleman J; Chen RH
    Cancer Res; 2008 Oct; 68(19):7779-87. PubMed ID: 18829532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal-growth-factor-dependent activation of the src-family kinases.
    Osherov N; Levitzki A
    Eur J Biochem; 1994 Nov; 225(3):1047-53. PubMed ID: 7525285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk.
    Mitchell PJ; Barker KT; Shipley J; Crompton MR
    Oncogene; 1997 Sep; 15(12):1497-502. PubMed ID: 9333026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest.
    Lukong KE; Huot ME; Richard S
    Cell Signal; 2009 Sep; 21(9):1415-22. PubMed ID: 19439179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition.
    Qiu H; Miller WT
    J Biol Chem; 2002 Sep; 277(37):34634-41. PubMed ID: 12121988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor (EGF) modulation of feline sarcoma virus fms tyrosine kinase activity, internalization, degradation, and transforming potential in an EGF receptor/v-fms chimera.
    Riedel H
    J Virol; 1994 Jan; 68(1):411-24. PubMed ID: 8254751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function.
    Biscardi JS; Maa MC; Tice DA; Cox ME; Leu TH; Parsons SJ
    J Biol Chem; 1999 Mar; 274(12):8335-43. PubMed ID: 10075741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracing the footprints of the breast cancer oncogene BRK - Past till present.
    Goel RK; Lukong KE
    Biochim Biophys Acta; 2015 Aug; 1856(1):39-54. PubMed ID: 25999240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
    Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE
    PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR.
    Li X; Lu Y; Liang K; Hsu JM; Albarracin C; Mills GB; Hung MC; Fan Z
    Oncogene; 2012 Oct; 31(40):4372-83. PubMed ID: 22231447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.